How can a pathway-oriented framework improve the clinical understanding and management of inborn errors of metabolism beyond traditional biochemical classifications? Authors Brendan Lee and Fernando Scaglia, both established experts in medical genetics, synthesize molecular data with clinical practice to redefine IEMs as complex, systemic diseases. They argue that by viewing metabolic alterations through a pathway-based lens, clinicians can better anticipate secondary and tertiary physiological effects, thereby improving diagnostic accuracy and long-term patient outcomes.

Medical professionals and geneticists frequently cite this volume as a critical resource for moving beyond static biochemical descriptions toward a more dynamic, systems-based approach to metabolic medicine. Experts highlight the text's utility in bridging the gap between laboratory research and bedside clinical application.